Works about VASCULAR endothelial growth factor antagonists

Results: 1692
    1
    2
    3
    4
    5

    Faricimab for treatment-resistant choroidal neovascularization (CNV) in neovascular age-related macular degeneration (nAMD): seven-months results using artificial intelligence and OCTA.

    Published in:
    International Journal of Retina & Vitreous, 2025, v. 11, n. 1, p. 1, doi. 10.1186/s40942-025-00691-4
    By:
    • Heinke, Anna;
    • Warter, Alexandra;
    • Nagel, Ines D.;
    • Agnihotri, Akshay;
    • Mehta, Nehal Nailesh;
    • Galang, Carlo Miguel B.;
    • Deussen, Daniel N.;
    • Bartsch, Dirk-Uwe G.;
    • Cheng, Lingyun;
    • Ferreyra, Henry A.;
    • Freeman, William R.
    Publication type:
    Article
    6
    7
    8
    9
    10

    Capturing the transition from intermediate to neovascular AMD: Longitudinal changes in choroidal volume and choroidal vascularity index.

    Published in:
    Graefe's Archive of Clinical & Experimental Ophthalmology, 2025, v. 263, n. 5, p. 1289, doi. 10.1007/s00417-025-06767-z
    By:
    • Borrelli, Enrico;
    • Mohammed, Abdul Rasheed;
    • Barresi, Costanza;
    • Vupparaboina, Kiran Kumar;
    • Viggiano, Pasquale;
    • Boscia, Francesco;
    • Berni, Alessandro;
    • Introini, Ugo;
    • Reibaldi, Michele;
    • Bandello, Francesco;
    • Chhablani, Jay
    Publication type:
    Article
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50